[1]
Zhu, J.; Xu, Y.; Liu, S.; Qiao, L.; Sun, J.; Zhao, Q. 2020, MicroRNAs associated with colon cancer:New potential prognostic markers and targets for
therapy. Front. Bioeng. Biotechnol., 2020.
[http://dx.doi.org//10.3389/fbioe.2020.00176]
[http://dx.doi.org//10.3389/fbioe.2020.00176]
[2]
Feng, Y.; Zhang, Y.; Zhou, D.; Chen, G.; Li, N. 2019 MicroRNAs, intestinal inflammatory and tumor. Bioorg. Med. Chem. Lett., 2019.
[http://dx.doi.org/10.1016/j.bmcl.2019.06.013]
[http://dx.doi.org/10.1016/j.bmcl.2019.06.013]
[3]
He, X.X.; Chang, Y.; Meng, F.Y.; Wang, M.Y.; Xie, Q.H.; Tang, F.; Li, P.Y.; Song, Y.H.; Lin, J.S. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene, 2012, 31(28), 3357-3369.
[http://dx.doi.org//10.1038/onc.2011.500] [PMID: 22056881]
[http://dx.doi.org//10.1038/onc.2011.500] [PMID: 22056881]
[4]
Shi, C.; Yang, Y.; Xia, Y.; Okugawa, Y.; Yang, J.; Liang, Y.; Chen, H.; Zhang, P.; Wang, F.; Han, H.; Wu, W. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer. Gut, 2016, 65(9), 1470-1481.
[http://dx.doi.org/10.1136/gutjnl-2014-308455] [PMID: 25994220]
[http://dx.doi.org/10.1136/gutjnl-2014-308455] [PMID: 25994220]
[5]
Mima, K.; Nishihara, R.; Yang, J.; Dou, R.; Masugi, Y.; Shi, Y.; Da Silva, A.; Cao, Y.; Song, M.; Nowak, J.; Gu, M. MicroRNA MIR21 (miR-21) and PTGS2 expression in colorectal cancer and patient survival. Clin. Cancer Res., 2016, 22(15), 3841-3848.
[http://dx.doi.org// 10.1158/1078-0432.CCR-15-2173] [PMID: 26957558]
[http://dx.doi.org// 10.1158/1078-0432.CCR-15-2173] [PMID: 26957558]
[6]
Jothimani, G.; Sriramulu, S.; Chabria, Y.; Sun, X.F.; Banerjee, A.; Pathak, S. A review on theragnostic applications of microRNAs and long non-coding RNAs in colorectal cancer. Curr. Top. Med. Chem., 2018, 19(30)
[http://dx.doi.org//10.2174/1568026619666181221165344]
[http://dx.doi.org//10.2174/1568026619666181221165344]
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Emerging Importance of microRNA in Early Detection of Colorectal Cancer
Volume: 21 Issue: 1
Author(s): Surajit Pathak and Antara Banerjee
Affiliation:
Export Options
About this article
Cite this article as:
Pathak Surajit and Banerjee Antara , Emerging Importance of microRNA in Early Detection of Colorectal Cancer, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (1) . https://dx.doi.org/10.2174/187153032101201210095139
DOI https://dx.doi.org/10.2174/187153032101201210095139 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science Inhibition of Disulfide Reductases as a Therapeutic Strategy
Current Enzyme Inhibition Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches
Current Pharmaceutical Design Natural History of Ulcerative Colitis: Current Knowledge
Current Drug Targets IP6 (Inositol Hexaphosphate) as a Signaling Molecule
Current Signal Transduction Therapy Boronic Acid-based Enzyme Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) MicroRNAs as Cancer Biomarkers
MicroRNA Prediction of Michaelis-Menten Constant of Beta-Glucosidases Using Nitrophenyl-beta-D-Glucopyranoside as Substrate
Protein & Peptide Letters iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Using NMR to Develop New Allosteric and Allo-Network Drugs
Current Drug Discovery Technologies QSAR and Molecular Docking Techniques for the Discovery of Potent Monoamine Oxidase B Inhibitors: Computer-Aided Generation of New Rasagiline Bioisosteres
Current Topics in Medicinal Chemistry Editorial (Hot Topic: Vitamin D and Cancer: Current Evidence and Future Perspective)
Anti-Cancer Agents in Medicinal Chemistry Tools For Decision-Making In Older Cancer Patients. Role Of The Comprehensive Geriatric Assessment
Anti-Cancer Agents in Medicinal Chemistry Advances in Imaging Gene-Directed Enzyme Prodrug Therapy
Current Pharmaceutical Biotechnology Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Current Computer-Aided Drug Design